
Ponatinib-blinatumomab lifts 2-year EFS to 86% in Ph+ ALL
10/21/2026
0:00
12:09
Editor's Pick: Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL (New England Journal of Medicine, 2026)
This AudioScholar briefing is generated by artificial intelligence for healthcare professionals and trainees. It is not medical advice.
Welcome to This Week in Hematology. This week we're covering 10 notable papers spanning chemotherapy-free and residual-disease-guided approaches in acute leukemia, a fresh look at myeloproliferative neoplasms, and the promise and pitfalls of curative…
This week's papers:
1. Ponatinib-Blinatumomab or Imatinib-Chemotherapy for Adult Ph-Positive ALL.. New England Journal of Medicine 2026.
2. Flow MRD pre-blinatumomab consolidation, despite subsequent clearance, is associated with inferior survival in Ph+ B-ALL.. Blood Advances 2026.
3. A randomized phase 2 study combining midostaurin, low-dose cytarabine and venetoclax in newly diagnosed AML ≥60 years.. Blood 2026.
4. American Society of Hematology 2026 Guidelines for the Management of Myelofibrosis in Adults.. Blood Advances 2026.
5. Incidence of thrombosis and bleeding in patients with JAK2- positive myeloproliferative neoplasms receiving low-dose aspirin: a systematic review and meta-anal…. Journal of Thrombosis and Haemostasis 2026.
6. National Alliance of Sickle Cell Disease Consensus Recommendations for Gene Therapy Implementation.. Blood Advances 2026.
7. Sustained improvement in sickle cell cardiomyopathy after haematopoietic stem cell transplantation is superior to that with disease-modifying therapy.. British Journal of Haematology 2026.
8. Cases of High-Titer Inhibitor Formation After AAV Gene Therapy for Hemophilia A.. Blood 2026.
9. Clinical characteristics and outcome of a cohort of CLL patients with BTK T474 gatekeeper mutation.. Blood Advances 2026.
10. Molecular predictors of minimal residual disease in newly diagnosed multiple myeloma treated with quadruplet therapy.. Nature Medicine 2026.
Listen at https://audioscholar.cc/episode/jemyngahqs
More episodes from "AudioScholar Hematology Weekly (India)"



Don't miss an episode of “AudioScholar Hematology Weekly (India)” and subscribe to it in the GetPodcast app.








